Figure 4.

α-Hederin reduces glycolytic levels by inhibiting c-Myc and HIF-1α in human non-small cell lung cancer A549 cells. A549 cells were treated with α-hederin for 24 h. Expression of c-Myc, Akt, HIF-1α, and p53 was detected by western blots.